Video Latest - ecancer

Immune cells in tumours may identify breast cancer patients most likely to benefit from trastuzumab

Dr Sherene Loi - Peter MacCallum Cancer Centre, Melbourne, Australia

12 Dec 2013

BETH study: highly effective treatment option for patients with HER2 breast cancer

Dr Dennis Slamon - University of California, Los Angeles

12 Dec 2013

Treating ALL patients with T cells targeted for CD19

Dr Laurence Cooper - MD Anderson Cancer Center, Houston, USA

8 Dec 2013

Transplantation and short telomeres increase the risk of cognitive impairment

Dr Smita Bhatia - City of Hope National Medical Center, Duarte, California

8 Dec 2013

Plurality of cancer

Dr Raghunadharao Digumarti - Nizam's Institute of Medical Sciences, Hyderabad, India

5 Dec 2013

Growing rate of cancer incidence in India

Dr Sidharth Sahni - BLK Cancer Centre, New Delhi, India

4 Dec 2013

Translating guidelines from the West to the Indian sub-continent

Dr Anil D'Cruz - Director, Tata Memorial Hospital, Mumbai, India

4 Dec 2013

Cancer cells and the immune system: a natural story?

Prof. Laurence Zitvogel - INSERM, Institut Gustave Roussy, Villejuif, France

3 Dec 2013

Immuno-Oncology: the next new paradigm in cancer treatment? Chairman's welcome and introduction

Prof. Winald Gerritsen - Radboud University Nijmegen Medical Centre, The Netherlands

3 Dec 2013

Immuno-Oncology: a concept or already a reality?

Prof. Peter Johnson - Cancer Research UK Centre, University of Southampton, UK

3 Dec 2013

Why are Immuno-Oncology compounds different?

Prof. Enriqueta Felip - Vall d'Hebron University Hospital, Barcelona, Spain

3 Dec 2013

Investigating tumour subtypes of Kaposi's Sarcoma

Dr Aron Abera - MRC/Research Group for Receptor Biology, IIDMM, University of Cape Town, South Africa

2 Dec 2013

Video